Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b

Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b

US Patent 6830744 · Granted Dec 14, 2004

Estimated economic value: $2,364,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2023
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2023
Metabolism resistant fenfluramine analogs and methods of using the same2023
Ketogenic diet compatible fenfluramine formulation2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2022
Metabolism resistant fenfluramine analogs and methods of using the same2022
Compositions and methods involving polymer, solvent, and high viscosity liquid c2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2021
Metabolism resistant fenfluramine analogs and methods of using the same2020
Ketogenic diet compatible fenfluramine formulation2020
Formulation for inhibiting formation of 5-HT2B agonists and methods of using sam2020
Compositions and methods involving polymer, solvent, and high viscosity liquid c2019